IFNGR1 and breast cancer: Research has suggested that interferon gamma (IFN-γ), an immune potentiating agent, favours activation of mitochondrial-operated apoptotic pathway in breast cancer cell lines by interacting with its receptor, interferon gamma receptor 1 (IFNGR1) [21].